Literature DB >> 19221829

Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.

Burak Turgut1, Peykan Turkcuoglu, Süleyman Serdar Koca, Orhan Aydemir.   

Abstract

Hydroxychloroquine (HCQ) that is widely used in the treatment of the connective tissue disorders can cause retinopathy. The fundus examination of a patient with systemic lupus erythematosus receiving HCQ revealed left incomplete bull's eye and pigmentary changes in macula in the right eye. Repeated visual field tests showed the paracentral and peripheral defects in the right eye and the pericentral ring scotoma in the left eye. Optical coherence tomography (OCT) scans revealed the photoreceptor loss, retina pigment epithelium (RPE) irregularities, and a cyst-like hypo reflective space over RPE layer on the nasal perifoveal region in the left eye. On the ophthalmoscopic examination, the perifoveal pigmentation was not altered after the discontinuation of HCQ. However, the bilateral visual field defects were improved and the photoreceptor destruction and cyst-like hyporeflective space disappeared in the left eye. Mild RPE irregularities remained in both eyes as revealed by OCT scans. Even if OCT is used to evaluate the regression of HCQ retinopathy, it only shows advanced stage of retinopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221829     DOI: 10.1007/s10067-009-1108-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

1.  Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.

Authors:  Michael F Marmor; Ronald E Carr; Michael Easterbrook; Ayad A Farjo; William F Mieler
Journal:  Ophthalmology       Date:  2002-07       Impact factor: 12.079

2.  HISTOPATHOLOGY OF CHLOROQUINE RETINAL TOXICITY.

Authors:  D H WETTERHOLM; F C WINTER
Journal:  Arch Ophthalmol       Date:  1964-01

3.  High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.

Authors:  Julio A Rodriguez-Padilla; Thomas R Hedges; Bryan Monson; Vivek Srinivasan; Maciej Wojtkowski; Elias Reichel; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Arch Ophthalmol       Date:  2007-06

Review 4.  Ocular toxicity of hydroxychloroquine.

Authors:  J C S Yam; A K H Kwok
Journal:  Hong Kong Med J       Date:  2006-08       Impact factor: 2.227

5.  The ocular safety of hydroxychloroquine.

Authors:  M Easterbrook
Journal:  Semin Arthritis Rheum       Date:  1993-10       Impact factor: 5.532

6.  Hydroxychloroquine retinopathy.

Authors:  A Weiner; M A Sandberg; A R Gaudio; M M Kini; E L Berson
Journal:  Am J Ophthalmol       Date:  1991-11-15       Impact factor: 5.258

  6 in total
  6 in total

Review 1.  [Progressive maculopathy despite discontinuation of chloroquine treatment-multimodal imaging and review of the literature].

Authors:  A Rickmann; S Al-Nawaiseh; L Ramirez; S Röhrig; M Ladewig; P Szurman; G Szurman
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

Review 2.  Hydroxychloroquine retinopathy.

Authors:  I H Yusuf; S Sharma; R Luqmani; S M Downes
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

3.  A comparison of multifocal ERG and frequency domain OCT changes in patients with abnormalities of the retina.

Authors:  Elizabeth A Dale; Donald C Hood; Vivienne C Greenstein; Jeffrey G Odel
Journal:  Doc Ophthalmol       Date:  2009-12-31       Impact factor: 2.379

4.  Role of optical coherence tomography in the early detection of macular thinning in rheumatoid arthritis patients with chloroquine retinopathy.

Authors:  Marija S Trenkic Božinovic; Gordana Stankovic Babic; Maja Petrovic; Jelena Karadžic; Tatjana Šarenac Vulovic; Milan Trenkic
Journal:  J Res Med Sci       Date:  2019-06-25       Impact factor: 1.852

5.  Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine.

Authors:  Yigit Ulviye; Tugcu Betul; Tarakcioglu Hatice Nur; Celik Selda
Journal:  Indian J Ophthalmol       Date:  2013-04       Impact factor: 1.848

6.  Multifocal ERG Guiding Therapy in a Case of Hydroxychloroquine Premaculopathy.

Authors:  José Antonio Sáez-Moreno; Concepción Domínguez-Hidalgo; José Manuel Rodríguez-Ferrer
Journal:  Case Rep Ophthalmol Med       Date:  2015-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.